INTONE™ FOR URINARY INCONTINENCE: MUSCLE STIMULATION, FEEDBACK, TRACKING
InTone from InControl Medical, LLC, is a Class II FDA-cleared device that combines intravaginal muscle stimulation, exercises, biofeedback, and data reporting. A sensor in the device measures pressure to determine if the patient is doing the exercises properly while mild microcurrent stimulates the muscles. The biofeedback unit provides voice-guided instruction as the patient follows a daily 10-minute routine. Data records muscle isolation and strength on the hand-held controller; information can be downloaded into the clinician’s computer for review.
FOR MORE INFORMATION, VISIT www.incontrolmedical.com
IROUNDS™ OFFERS MOBILE/WEB PLATFORMS TO ENHANCE PHYSICIAN COMMUNICATION
iRounds.net was built to enable ObGyn physicians to communicate with each other, share call schedules, follow appointments, allow cross-coverage, and provide patient sign-out capabilities. Communication is secure, encrypted, and HIPAA-compliant. The physician’s office staff can interact to enter patient information, schedule procedures, update the call schedule, etc. Secure MD-to-MD calls can be made.
FOR MORE INFORMATION, VISIT www.irounds.net
USE GUIDEBOOK FROM AMA TO VERIFY INSURER-PROVIDED PROFILE REPORTS
Take Charge of Your Data is a new guidebook from the American Medical Association to help physicians understand and verify the accuracy of complex profile reports provided by health insurers based on collected claims data. Physicians need to confirm the accuracy of the practice data collected by insurers because these data drive public reporting, pay-for-performance, physician tiering, and narrow network programs. Using practical information and clear instructions, the guide simplifies the process of reviewing profile reports. The guide and supplementary standard report are available free to all physicians at the AMA’s Practice Management Center.
FOR MORE INFORMATION, VISIT http://bit.ly/OWERPLs
DIGICHART PROVIDES EHR AND PRACTICE MANAGEMENT TOOLS
digiChart OB-GYN, from digiChart, Inc, is a speciality-specific electronic health record (EHR) product developed to enhance ObGyn patient care and meet meaningful use requirements. PracticeSmart is an integrated EHR and practice management tool that allows the clinical, administrative, and financial parts of an ObGyn practice to “talk” to each other, mimicking typical office workflow. digiChart says its EHR program is preloaded with easy-to-edit ObGyn clinical treatment plans; there are no templates to build. The online patient portal and e-prescribing module are fully integrated and included in the pricing structure. All digiChart products run on an Internet-based platform to reduce cost and maintenance, increase security, and allow for automatic updates.
FOR MORE INFORMATION, VISIT www.digichart.com
MIFEPREX —TO END EARLY PREGNANCY
Mifeprex (mifepristone) from Danco Laboratories, is an FDA-approved nonsurgical option used alone or in combination with misoprostol to end an early pregnancy (within 49 days of the beginning of the patient’s last menstrual period). Taken orally by prescription only, this antiprogestational steroid blocks the activity of progesterone, which is required to maintain pregnancy. Mifeprex should not be used in cases of confirmed or suspected ectopic pregnancy (read Important Safety Information). Mifeprex is also used to treat tumors of the brain, endometriosis, and fibroids, or to induce labor.
FOR MORE INFORMATION, VISIT www.earlyoptionpill.com